Advertisement

Picture biomindz Mainz Biomed LSE Colorectal Cancer Screening 650x100px
Organisation › Details

GO Capital (FR)

GO Capital is an independent venture capital firm that manages over €170 million ($200M) and invests primarily in high-tech companies located in Western and Central France, in the fields of energy, the digital economy, life sciences and industry services. GO CAPITAL invests in companies via several funds (GO Capital Amorçage and Ouest Ventures), from their creation to their expansion worldwide, in order to boost their development. It now has 41 companies in its portfolio. The Ouest Ventures III fund, which invests in Pherecydes, brings together investors from the West of France, Bpifrance, the Bretagne and Pays de la Loire regions, as well as banking partners (BNP Paribas, BPO, BPA, CIC Ouest, CM Arkea). *

 

Period Start 2016-07-08 existent
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Person Person Nicolas, Leila (Go Capital (FR) 201801 Investment Director)
     
Region Region Rennes
  Country France
  Street 1A rue Louis Braille Courrouze
  City 35136 Saint Jacques de la Lande (Rennes)
  Tel +33-2-9935-0400
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
  Currency EUR
  Annual sales 170,000,000 (capital under management 2018-01-16)
     
    * Document for »About Section«: 
     
   
Record changed: 2024-03-30

Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

More documents for GO Capital (FR)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture biomindz TRON LSE Mainz Translation Cancer Immunotherapy 650x300px




» top